Men C Vaccination
Research and careful monitoring of the vaccination programme shows that the direct protection young children get from Meningitis C vaccination is relatively short lived. This means that babies who were vaccinated in 1999/2000 will now be teenagers who are no longer directly protected from this serious illness, which means that they are vulnerable to Meningitis C.
Meningococcal disease can affect all age groups, but the rates of disease are highest in children under five years of age, with the peak incidence in those under one year of age. There is a second peak in incidence in young people aged 15 to 19 years of age.
Although cases of Meningitis C are at a historically low level, it is important to vaccinate this age group to protect all teenagers and maintain protection amongst the population at large.
The European Vaccination Group will be offering your teenager the Meningitis C booster in school. The changes to the schedule will make the overall Meningitis C immunisation programme more effective and offer greater protection to teenagers. Students in Year 9 each academic year will be offered this vaccination.